跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PMS-DOLUTEGRAVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PMS-DOLUTEGRAVIR
Authorized
STANDARD
PMS-DOLUTEGRAVIR
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
361fd86b9061ca54
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
361fd86b9061ca54
Drug Approval Canada Name
PMS-DOLUTEGRAVIR
Product Name
PMS-DOLUTEGRAVIR
Status
Approved
Status Date
2026-04-14
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Atc Original
J05AJ03 DOLUTEGRAVIR
Aig Number
0154870001
Company Name
Pharmascience Inc
Company Address
100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
361fd86b9061ca54
Type
Standard
Back to Health Canada Approvals